Supreme Healthcare IPO Nepal: Invest in a Leading Pharma Company via Global IME Capital
30th April 2025, Kathmandu
Supreme Healthcare, a leading pharmaceutical company in Nepal, has revealed plans to issue an Initial Public Offering (IPO). The company will offer 1.25 million shares to the public for NPR 100 per share. This move is aimed at raising funds to support future growth and strengthen its financial structure.
Supreme Healthcare IPO Nepal
To manage the IPO process, Supreme Healthcare has selected Global IME Capital as the issue and sales manager. The official agreement was signed by Mukesh Sharma, Executive Director of Supreme Healthcare, and Mandeep Luitel, CEO of Global IME Capital. The signing ceremony took place on 15th Baishakh 2082 (April 28, 2025) at the central office of Global IME Capital in Naxal.
A Step Toward Expansion
Supreme Healthcare, established in 2009 (2066 BS), has grown to become a key player in Nepal’s pharmaceutical industry. The company offers over 85 products across more than 35 therapeutic categories. Popular products like Pendom-SR, Amlospair-L, and Metspair-G 2 Fort have earned it a strong reputation for quality and effectiveness.
The decision to go public will provide Supreme Healthcare with the capital necessary to expand its operations. This IPO will help the company increase production capacity, enhance its product portfolio, and continue serving the growing healthcare needs of Nepal. With Global IME Capital handling the process, Supreme Healthcare is confident in the IPO’s success.
Commitment to Social Good
Beyond business, Supreme Healthcare is committed to social responsibility. The company regularly organizes free health camps, distributes medicines, and runs health literacy programs in various parts of Nepal. These initiatives aim to improve public health and raise awareness about important healthcare issues.
Mukesh Sharma, Executive Director of Supreme Healthcare, expressed his excitement about the IPO. He said, “This public offering will help us further strengthen our operations and continue providing high-quality healthcare products to the community.”
Track Record of Success
Supreme Healthcare has enjoyed steady growth since its inception. Over the last six years, the company has consistently generated profits and strengthened its market position. Its registered office is located in Parwanipur, Bara, while its contact office is in Ghanapokhari, Kathmandu.
With the IPO, Supreme Healthcare expects to boost its capital structure and continue its expansion. This public offering will also help the company explore new opportunities in the pharmaceutical market. It is a strategic step to ensure long-term sustainability and growth.
Looking Toward the Future
Supreme Healthcare’s IPO marks a major milestone in the company’s journey. The funds raised will support the expansion of its product offerings and production capacity. The company also plans to continue its CSR initiatives, benefiting communities across Nepal.
Investors are eagerly awaiting the IPO, hoping for long-term returns. As Supreme Healthcare prepares to list its shares, the pharmaceutical company’s future looks promising. The IPO is expected to contribute to the company’s continued success and its efforts to improve the healthcare system in Nepal.
For more: Supreme Healthcare IPO Nepal
